V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20215364 | 20130372 | 1.72 | 98 | Palliative (P) | 2016-12-19 | 2017-01-10 | Oxaliplatin + Raltitrexed | 02 | N | OXALIPLATIN + RALTITREXED | 101452528 |
| 20215365 | 20130373 | 1.76 | 105 | Palliative (P) | 2016-09-17 | 2016-09-27 | Trial Unspecified | 02 | N | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 101375192 |
| 20215366 | 20130374 | 1.53 | 100.5 | null | 2018-09-19 | 2019-02-23 | EOX | 02 | null | SORAFENIB | 101777888 |
| 20215367 | 20130375 | 1.74 | 117 | null | 2019-06-24 | 2019-07-14 | Oxaliplatin + Raltitrexed | 02 | Y | OXALIPLATIN + RALTITREXED | 101337808 |
| 20215371 | 20130376 | 1.82 | 80 | Palliative (P) | 2019-05-03 | 2019-05-03 | Sorafenib | 02 | N | SORAFENIB | 101781786 |
| 20215372 | 20130377 | 1.75 | 106.5 | Neo-adjuvant (N) | 2019-03-07 | 2019-03-12 | CAPECITABINE + RT | N | Y | CAPECITABINE + RT | 101201343 |
| 20215373 | 20130378 | 1.45 | 48 | null | 2019-02-21 | 2019-02-21 | IRINOTECAN + MDG + PANITUMUMAB | 02 | N | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 100521098 |
| 20215374 | 20130379 | 1.66 | 72.5 | Palliative (P) | 2018-10-10 | 2018-11-15 | Sorafenib | 02 | N | SORAFENIB | 100984879 |
| 20215375 | 20130380 | null | null | Curative (C) | 2018-05-25 | 2018-05-26 | EOX | 02 | N | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 101043799 |
| 20215378 | 20130381 | 1.57 | 64 | Palliative (P) | 2019-03-08 | 2019-03-17 | Trial Unspecified | Y | N | TRIAL | 101336553 |
| 20215380 | 20130382 | 1.74 | 115.7 | Curative (C) | 2018-07-03 | 2018-07-23 | CAPECITABINE + RT | N | Y | CAPECITABINE + RT | 101051056 |
| 20215382 | 20130383 | 1.76 | 74.7 | Curative (C) | 2019-04-15 | 2019-04-29 | Oxaliplatin + Raltitrexed | 02 | Y | OXALIPLATIN + RALTITREXED | 101317150 |
| 20215383 | 20130384 | 1.61 | 74 | Palliative (P) | 2020-08-24 | 2020-09-11 | Sorafenib | N | N | SORAFENIB | 100469529 |
| 20215384 | 20130385 | 1.52 | null | Palliative (P) | 2019-07-17 | 2019-08-31 | EOX | 02 | N | CETUXIMAB + IRINOTECAN + MDG | 100170904 |
| 20215385 | 20130386 | 1.51 | 109 | Palliative (P) | 2019-08-11 | 2019-09-01 | EOX | 02 | N | OXALIPLATIN + RALTITREXED | 100386693 |
| 20215388 | 20130387 | 1.81 | 66.2 | Neo-adjuvant (N) | 2018-07-18 | 2018-07-28 | Cetuximab + Oxaliplatin + MdG Maint | 02 | N | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 101772614 |
| 20215389 | 20130388 | 1.75 | 71.9 | Adjuvant (A) | 2019-02-13 | 2019-02-13 | EOX | 02 | N | EOX | 101009639 |
| 20215390 | 20130389 | 1.57 | 114.4 | null | 2018-08-23 | 2018-12-09 | CAPECITABINE + RT | 02 | null | CAPECITABINE + RT | 100711634 |
| 20215392 | 20130390 | null | null | Palliative (P) | 2020-03-27 | 2020-03-28 | Sorafenib | 01 | N | EOX | 100944746 |
| 20215395 | 20130391 | 1.67 | 55.8 | null | 2018-11-12 | 2018-11-13 | Trial Unspecified | N | null | TRIAL | 100568449 |
| 20215397 | 20130392 | 1.76 | 65.4 | Neo-adjuvant (N) | 2019-04-29 | 2019-04-29 | Cetuximab + FLUOROURACIL + OXALIPLATIN | 02 | N | CAPECITABINE + RT | 100150669 |
| 20215399 | 20130393 | 1.79 | null | null | 2019-10-15 | 2019-10-17 | Panitumumab + Irinotecan + MdG | 02 | null | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 101588104 |
| 20215400 | 20130394 | 1.69 | 101.3 | Palliative (P) | 2017-10-21 | 2018-05-12 | EOX | 2 | N | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 101715243 |
| 20215403 | 20130395 | 1.66 | 60.5 | Curative (C) | 2017-04-21 | 2017-04-30 | EOX | 02 | Y | EOX | 100550894 |
| 20215404 | 20130396 | 1.75 | 99 | null | 2020-05-19 | 2020-05-27 | CAPECITABINE + RT | 02 | null | CAPECITABINE + RT | 101527618 |
| 20215408 | 20130397 | 1.75 | 95.8 | Palliative (P) | 2017-12-29 | 2017-12-29 | Sorafenib | 02 | N | SORAFENIB | 100976664 |
| 20215413 | 20130398 | 1.73 | 76.2 | Palliative (P) | 2016-10-05 | 2017-02-01 | IRINOTECAN + MDG + PANITUMUMAB | 02 | N | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 100988285 |
| 20215415 | 20130399 | 1.55 | 50 | Palliative (P) | 2018-09-12 | 2018-10-17 | EOX | 02 | N | CETUXIMAB + IRINOTECAN + MDG | 100805659 |
| 20215417 | 20130400 | 1.6 | 82 | Neo-adjuvant (N) | 2019-03-13 | 2019-04-14 | CAPECITABINE + RT | 99 | N | CAPECITABINE + RT | 101228387 |
| 20215419 | 20130401 | 1.6 | 72.2 | Palliative (P) | 2019-07-08 | 2019-07-25 | EOX | 2 | N | CETUXIMAB + IRINOTECAN + MDG | 101006178 |
| 20215420 | 20130402 | 1.62 | 62.6 | Palliative (P) | 2016-05-21 | 2016-06-03 | Sorafenib | 2 | N | TRIAL | 101365679 |
| 20215421 | 20130403 | 1.58 | 70.6 | null | 2018-07-27 | 2018-08-15 | EOX | N | null | EOX | 100835833 |
| 20215422 | 20130404 | 1.7 | 66 | null | 2016-09-24 | 2016-10-09 | EOX | 2 | null | CETUXIMAB + IRINOTECAN + MDG | 100248825 |
| 20215424 | 20130405 | 1.86 | 79.4 | Palliative (P) | 2017-10-16 | 2018-11-23 | EOX | 02 | N | EOX | 100294122 |
| 20215429 | 20130406 | 1.5 | 82.6 | Disease modification (D) | null | null | EOX | 02 | Y | CETUXIMAB + IRINOTECAN + MDG | 100115985 |
| 20215430 | 20130407 | null | 84 | Palliative (P) | 2015-08-02 | 2016-07-23 | Capecitabine 42days + RT | 02 | N | CAPECITABINE + RT | 101228771 |
| 20215431 | 20130408 | 1.69 | 65 | Palliative (P) | 2019-01-31 | 2019-02-06 | EOX | 02 | N | EOX | 101336993 |
| 20215433 | 20130409 | 1.52 | 46.2 | Palliative (P) | 2019-07-06 | 2019-07-22 | EOX | N | null | TRIAL | 100254615 |
| 20215437 | 20130410 | 1.53 | 50 | Neo-adjuvant (N) | 2016-10-23 | 2016-11-12 | Trial Unspecified | N | N | TRIAL | 100782167 |
| 20215438 | 20130411 | 1.86 | 62.8 | Palliative (P) | 2019-06-11 | 2019-07-12 | EOX | 02 | N | CETUXIMAB + IRINOTECAN + MDG | 101292259 |
| 20215441 | 20130412 | 1.55 | 96 | Neo-adjuvant (N) | 2017-07-13 | 2017-07-13 | Sorafenib | 02 | Y | SORAFENIB | 101564484 |
| 20215442 | 20130413 | 0 | 108.4 | Palliative (P) | 2020-12-26 | 2020-12-26 | EOX | N | null | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 101053406 |
| 20215444 | 20130414 | 1.62 | 78.5 | Neo-adjuvant (N) | 2019-03-01 | 2019-06-14 | Trial Unspecified | 02 | N | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 101141866 |
| 20215445 | 20130415 | 1.57 | 50 | Palliative (P) | 2018-03-05 | 2018-03-20 | EOX | 2 | N | EOX | 101363802 |
| 20215448 | 20130416 | 1.69 | 55.8 | null | 2017-08-22 | 2017-08-24 | Sorafenib | 02 | null | SORAFENIB | 100187902 |
| 20215449 | 20130417 | 1.79 | 72.4 | Palliative (P) | 2019-10-07 | 2019-10-17 | EOX | Y | N | TRIAL | 101045602 |
| 20215453 | 20130418 | 0 | 44.3 | null | 2016-10-30 | 2016-11-09 | EOX | 99 | null | EOX | 101667425 |
| 20215456 | 20130419 | 1.72 | 90.1 | Palliative (P) | 2017-02-27 | 2017-09-24 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CETUXIMAB + IRINOTECAN + MDG | 101563720 |
| 20215461 | 20130420 | 1.82 | 94.6 | Palliative (P) | 2018-03-13 | 2018-04-30 | EOX | 02 | N | EOX | 100778569 |
| 20215466 | 20130421 | 1.74 | 66.4 | null | 2018-06-03 | 2018-06-08 | CAPECITABINE + RT | N | null | CAPECITABINE + RT | 101865156 |